Medicare beneficiaries with diagnosed diabetes (ASPE analysis)
Metric MA-01 · Series MA: Medicare
Medicare beneficiaries with diagnosed diabetes (ASPE analysis) was 26% in 2024, according to ASPE (HHS Office of the Assistant Secretary for Planning and Evaluation).
This figure is reported as Metric MA-01 in The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report (James M. Knox, DOI: 10.5281/zenodo.22772957).
Definition
This metric measures medicare beneficiaries with diagnosed diabetes (aspe analysis) among medicare beneficiaries. The unit of measurement is percent of Medicare beneficiaries. The geographic scope is United States.
Approximately 17.7 million people. Claims-based analysis finds prevalence closer to 20%; discrepancy documented in report.
Current Value
| Value | Data Year | Population | Geography |
|---|---|---|---|
| 26% | 2024 | Medicare beneficiaries | United States |
Source
ASPE (HHS Office of the Assistant Secretary for Planning and Evaluation).
Methodological Notes
This figure is drawn from ASPE (HHS Office of the Assistant Secretary for Planning and Evaluation). Where a second source reports a different figure for the same condition, both values and the reason for the discrepancy are documented in the report rather than reconciled.
See Methodology and Sources for the full source selection criteria and conflict resolution approach.
Related Metrics
- MA-02Medicare beneficiaries with diagnosed diabetes (claims-based)
- MA-03Medicare Diabetes Prevention Program active participants
- MA-04Prediabetes prevalence among adults aged 65 and older
- MA-05Medicare Advantage plans offering food and produce benefits
- MA-06Special Needs Plans offering food and produce benefits
Cite This Metric
Last reviewed: October 2026